71 related articles for article (PubMed ID: 1335787)
1. Manipulation of human B cells to confer immortality.
Jonak ZL; Henri E; Trulli S; Jensen CP; Muirhead KA
Hum Antibodies Hybridomas; 1992 Oct; 3(4):177-85. PubMed ID: 1335787
[TBL] [Abstract][Full Text] [Related]
2. Genetic engineering of human lymphocytes for the production of monoclonal antibodies.
Mally MI
Hum Antibodies Hybridomas; 1990; 1(1):27-33. PubMed ID: 1966472
[TBL] [Abstract][Full Text] [Related]
3. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
4. Development and distribution of a human B cell subpopulation identified by the HB-4 monoclonal antibody.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 Mar; 134(3):1539-44. PubMed ID: 3918104
[TBL] [Abstract][Full Text] [Related]
5. Mature murine B lymphocytes immortalized by Kirsten sarcoma virus.
Lichtman AH; Reynolds DS; Faller DV; Abbas AK
Nature; 1986 Dec 4-10; 324(6096):489-91. PubMed ID: 3024015
[TBL] [Abstract][Full Text] [Related]
6. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
Maruyama S; Kubagawa H; Cooper MD
J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
[TBL] [Abstract][Full Text] [Related]
7. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
9. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of EBV-transformable human B lymphocyte populations.
Chan MA; Stein LD; Dosch HM; Sigal NH
J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
[TBL] [Abstract][Full Text] [Related]
11. Cell surface phenotype, cytokines, and antibody gene expression in immortalized human B cell lines.
James K; Gardner J; Skibinski G; McCann M; Thorpe R; Gearing A; Gordon J
Hum Antibodies Hybridomas; 1990; 1(3):145-53. PubMed ID: 2103358
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.
Rosén A; Persson K; Klein G
J Immunol; 1983 Jun; 130(6):2899-902. PubMed ID: 6189902
[TBL] [Abstract][Full Text] [Related]
13. Herpesvirus saimiri-transformed human CD4+ T cells can provide polyclonal B cell help via the CD40 ligand as well as the TNF-alpha pathway and through release of lymphokines.
Saha K; Ware R; Yellin MJ; Chess L; Lowy I
J Immunol; 1996 Nov; 157(9):3876-85. PubMed ID: 8892618
[TBL] [Abstract][Full Text] [Related]
14. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide.
Little J; Alling DW; Asofsky R
J Immunol; 1993 Mar; 150(6):2129-38. PubMed ID: 8450206
[TBL] [Abstract][Full Text] [Related]
16. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
Ling NR; Lowe JA
Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279
[TBL] [Abstract][Full Text] [Related]
17. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
18. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
Jelinek DF; Lipsky PE
J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
[TBL] [Abstract][Full Text] [Related]
19. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
Storkus WJ; Dawson JR
J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
[TBL] [Abstract][Full Text] [Related]
20. Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.
Zola H; McNamara PJ; Moore HA; Smart IJ; Brooks DA; Beckman IG; Bradley J
Clin Exp Immunol; 1983 Jun; 52(3):655-64. PubMed ID: 6191892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
